BackDrugs Made In America Acquisition II Overview

Drugs Made In America Acquisition II Total Assets

Latest total assets for DMIIR: $510M.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$514.10M
↑ 453271.10% YoYΔ $513.99M vs prior year quarter

Peer trimmed avg / median

Loading

Drugs Made In America Acquisition II Total Assets History

Loading

Drugs Made In America Acquisition II vs. peers: Total Assets Comparison

Loading

Drugs Made In America Acquisition II Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Drugs Made In America Acquisition II (DMIIR) FAQ

As of the most recent data (June 2026), DMIIR shows a total assets of $510M. That compares with $110K in the prior-year period — up 453271.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, DMIIR's total assets is now $510M (was $110K) — a 453271.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Drugs Made In America Acquisition II is outperforming or lagging.

Tracking DMIIR's total assets over time shows whether Drugs Made In America Acquisition II is scaling, shrinking, or reshaping that part of the business. The current reading is $510M That compares with $110K in the prior-year period — up 453271.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has Drugs Made In America Acquisition II's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $510M) with ownership activity and broader fundamentals.